How deadly is Prostate cancer?

Azɔn nyanya tɛ ka nɔ hu mɛ ɖò kansɛ́ɛzɔn e nɔ nyí afɔnasin é mɛ?

Azɔnkwín adà tɔn ɔ́ wɛ́ nyí azɔnkwín wegɔ́ è nɔ́ hu mɛ lɛ́ɛ ɖò gbɛ ɔ́ mɛ̀ bɔ́ è ɖɔ̀ é ná yì gbɛtɔ́ 1.276 ɖò xwè 2018ɔ́ mɛ̀ bɔ́ é nɔ́ sɔ́ gbɛtɔ́ 7.1% ɖò gbɛtɔ́ lɛ́ɛ mɛ̀.

Kú sín kansɛ́n è nɔ hu mɛ ɖó kansɛ́n e nɔ hu mɛ ɖó afɔnasin xomɛ lɛ é wu lɔ ɖò jǐ, bɔ è ɖɔ ɖɔ é hu gbɛtɔ́ 37,005 ɖò gbɛ̀ ɔ mɛ ɖò xwè 2018 mɛ.

Amɔ̌, kú e nɔ sín mɛ wu é nɔ gbɔn vo tawun ɖò xá lɛ mɛ, bɔ gbadahweji aflika tɔn wɛ nyí atɔngɔ e ɖò awovinú ɖaxó hugǎn ɖó kansɛ́ɛzɔn e nɔ hu mɛ é wu ɖò gbɛ̀ ɔ mɛ é, bɔ Nigéria wɛ nyí tò e ɖó gbɛtɔ́ kpo akwɛzinzan kpo hugǎn ɖò xá enɛ mɛ é.

Ðò Nigéria ɔ, kansɛ́ɛ́li e nɔ hu mɛ é wɛ nyí kansɛ́ɛ́li e nɔ hu mɛ hugǎn ɖò sunnu lɛ mɛ é, bɔ è ɖɔ ɖɔ é nɔ hu gbɛtɔ́ 32,8 bɔ gbɛtɔ́ 16,3 nɔ kú ɖò gbɛtɔ́ 100,000 mɛ.

E nɔ hu mɛ azɔn we hú ée nɔ hu mɛ ɖò Amérique du Nord é.

Azɔn ɔ sín wuvɛ̌ mimɔ, akwɛ nabi è nɔ zán dó ba mɛ kpɔ́n bo lɛ́ mɔ mɛ ɔ, kpo mɛ ɖěɖee nɔ ɖó azɔn ɔ é kpò bo nɔ ɖó gbe na lɛ é kpo nɔ zɔ́n bɔ kú nɔ sukpɔ́ ɖò Nigéria.

Ðò États-Unis ɔ, kansɛ́ɛ e nɔ hu mɛ é wɛ nyí kansɛ́ɛ wegɔ e nɔ hu sunnu lɛ é, bɔ súnnu 40000 nɔ kú ɖó azɔn enɛ wu ɖò xwè ɖokpo ɖokpo mɛ.

Kú sín kansɛ́ɛ́zɔn e nɔ hu mɛ lɛ é nɔ ɖekpo kpɛɖé sín xwè 1990 lɛ mɛ, amɔ̌, é kpó ɖò tagba ɖaxó ɖé nyí nú lanmɛ na nɔ ganji wɛ.

Ðò kpaà mɛ ɔ, kansɛ́ɛ́zɔn e nɔ hu mɛ é nyí azɔn baɖabaɖa ɖé, ɖò taji ɔ ɖò xá ɖěɖee mɛ è ma ɖó dotóoxwé kpo azɔwanú e è nɔ zán dó ba do nú azɔn lɛ é kpo ɖè ǎ lɛ é.

Amɔ̌, enyi è mɔ azɔn ɔ ɖò hwenu é ɔ, è sixu gbɔ azɔn tɔn lɛ ganji, bɔ kú e mɛ lɛ nɔ kú é na ɖekpo.

['Nǔ ɖevo lɛ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.

Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.

Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.

Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.

Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.

['Nǔgbɛnúmɛ: dotóoxwé sín']

['Nǔkplɔnkplɔn kpo nǔsisɔ kpo sín azɔ̌ kɛɖɛ wɛ è nɔ wà dó tɛn ɛntɛnɛti tɔn elɔ jí, bo nɔ na wěɖexámɛ dotóoxwé tɔn alǒ azɔ̌ ɖevo lɛ mɛ ǎ.']

['È ɖó na zán nǔ e è kplɔ́n mɛ lɛ é dó ba azɔn ɖé alǒ azɔn ɖé sín wuntun alǒ dó gbɔ na ǎ, bɔ mɛ ɖěɖee jló na ba wěɖexámɛ dotóo tɔn lɛ é ɖó na yì mɔ dotóo e ɖó acɛ bo nɔ wà azɔ̌ ɖò dotóoxwé é ɖé.']

['Mi ni flín ɖɔ nǔ e è nɔ ylɔ ɖɔ "neural net" bo nɔ na xósin nú nǔkanbyɔ lɛ é ɔ, nǔ e nɔ nyí nǔjɛdo tawun é wɛ nyí nǔ ɖěɖee è nɔ ylɔ ɖɔ "numeric content" lɛ é. Ði kpɔ́ndéwú ɔ, mɛ nabi è mɔ azɔn ɖé na é.']

['Nɔ ba wěɖexámɛ dotóo towe tɔn alǒ dotóo ɖevo e ɖó nǔwukpikpé é tɔn dó azɔn ɖé wu hwebǐnu. Ma wɔn wěɖexámɛ dotóo tɔn lɛ gbeɖé ó, alǒ ma lin tamɛ kpɔ́n dó nǔ e a xà ɖò tɛn ɛntɛnɛti tɔn elɔ jí lɛ é wu ó. Enyi a lin ɖɔ azɔn baɖabaɖa ɖé ɖò xwi ɖí xá we wɛ hǔn, ylɔ 911 alǒ yì dotóoxwé e sɛkpɔ we hugǎn é tlolo. Tɛn ɛntɛnɛti tɔn elɔ alǒ nǔ e a nɔ zán lɛ é nɔ zɔ́n bɔ kancica dotóo-azinzɔnnɔ ɖé tɔn nɔ tíìn ǎ. BioMedLib, azɔ̌watɔ́ tɔn lɛ, alǒ mɛ ɖevo ɖebǔ e nɔ wlan nǔ dó tɛn ɛntɛnɛti tɔn elɔ jí lɛ é nɔ ɖè kúnnuɖenú ɖebǔ xlɛ́, bo tlɛ nɔ ɖɔ lɔ ǎ, dó nǔ e è ɖɔ ɖò fí lɛ é alǒ nǔ e è nɔ zán lɛ é wu.']

['Nǔɖògbɛ́jlatɔ́ lɛ']

['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) nɔ na acɛ mɛ e ɖó nǔɖokan yetɔn lɛ é bɔ ye na dó ba nǔɖe bo dó sixu mɔ nǔ e ye ɖó lɛ é ɖò Internet jí.']

["Enyi a ɖi nǔ ɖɔ nǔ ɖĕbǔ ɖò tɛn ɛntɛnɛti tɔn mǐtɔn jí alǒ azɔ̌wiwa mǐtɔn lɛ jí bo hɛn nǔ dó así nú mɛ ɔ, é xò nǔ dó acɛ nǔɖògbɛ́ towe lɛ wu ɔ, hwi (alǒ mɛ e nɔ kpé nukún dó wǔ towe é) sixu sɛ́ wɛn dó mǐ, bo byɔ ɖɔ mǐ ni ɖè nǔ ɖ'emɛ lɛ sín tɛn ɔ jí, alǒ ɖɔ mǐ ni sú ali dó mɛ."]

["È ɖó ná sɛ́ mɛ dó gbɔn email jí (e-mail è nɔ dó ɔ́' kpɔ́n 'Kɔntaktɔ́' ɔ́)."]

['DMCA byɔ ɖɔ ɖɔ nǔ elɔ lɛ ni nɔ akpáxwé nǔ e a ɖɔ é gbà acɛ dó nǔ é tɔn jí é: (1) xó dó azɔ̌ e ɖó acɛ dó nǔ é jí; (2) xó dó nǔ e ɖó acɛ dó nǔ é jí, kpo nǔ ɖevo e na zɔ́n bɔ mǐ na mɔ nǔ ɔ lɛ é kpo; (3) xó dó hwiɖée wu, ɖi adlɛsi towe, alokan towe kpo email towe kpo; (4) xó ɖɔ dó nǔ e wu a ɖi nǔ ɖɔ nǔ e ɖó acɛ dó nǔ e jí a ɖɔ é jí é kún nyí nǔ e ɖó acɛ dó nǔ é jí tɔn ɔ, alǒ mɛ e nɔ kpé nukún dó nǔ é tɔn wu é sín acɛ ó; ']

["(5) Ðɛ́ mɛ̀ è mi sɔ́ alɔ dó ɖ'así ná ɖò hwɛɖɔxɔsá ɔ́' è ɖó ná ɖó hwɛ̀ ɖɔ̀ xó è mi ɖɔ ɖò mɛ̀ è mi dó wèmá ɔ́ mɛ̀ ɔ́' sɔgbe bɔ̀ mi ɖó acɛ̀ bó ná dó ba ɖɔ è ní sú nǔ è è dó wèmá ɔ́ wú lɛ́ɛ sín axɔ́."]

['bɔ (6) alɔ wlanwlan mɛ e ɖó acɛ dó nǔ é tɔn alǒ mɛ e ɖó acɛ bo na wà nǔ dó wutu tɔn é tɔn. ']

['Nú a ma gɔ́ nǔ e ɖò jí lɛ é bǐ ǎ ɔ, é sixu zɔ́n bɔ è na lín có bo na dóhwɛ we.']

['Wǎ kpé mì']

['Mi kɛnklɛn bo sɛ́ nǔkanbyɔ mitɔn lɛ dó mǐ gbɔn e-mail jí.']

How deadly is prostate cancer?

Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.

The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.

However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.

In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.

This is more than double the death rate in North America.

Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.

In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.

The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.

Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.

However, early detection and treatment can significantly improve outcomes and reduce mortality rates.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.